Recent updates

Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma

Posted on11 Feb 2021

Comments0

Antibe Therapeutics Inc. licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company focused on licensing, developing and commercializing globally innovative therapies to...

Insight on why Jazz Pharmaceuticals to acquire GW Pharma?

Posted on11 Feb 2021

TagsEpidiolex, GW Pharma, Jazz Pharmaceuticals

Comments0

GW Pharmaceuticals announced they have entered into an agreement with Jazz Pharmaceutical. As per the agreement, Jazz to acquire GW Pharma. Both boards of directors for the two companies have...

ViiV Healthcare’s Rukobia received EMA marketing authorisation

Posted on10 Feb 2021

Tagsfostemsavir, HIV-1 attachment inhibitor, Rukobia, ViiV Healthcare

Comments0

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc and Shionogi Limited as shareholders, announced the European Marketing Authorisation of Rukobia (fostemsavir) 600mg...

Sanofi received additional indication approval for Plavix

Posted on10 Feb 2021

Tagsadditional indication approval, plavix, Sanofi

Comments0

European Commission (EC) has approved an additional indication for Plavix (clopidogrel) to include its use in combination with aspirin in adult patients with moderate to high-risk transient ischemic attack (TIA)...

CoronaVac received conditional marketing authorization from NMPA China

Posted on10 Feb 2021

Comments0

Sinovac Biotech announced that the China National Medical Products Administration (NMPA) has granted a conditional marketing authorization (CMA) to Sinovac for CoronaVac, Sinovac’s Covid-19 vaccine in individuals aged 18 and...

What is the meaning of pharmaceutical profiling?

Posted on13 Jan 2021

Tagspharmaceutical profiling

Comments0

Pharmaceutical profiling assays helps to measure the properties of large numbers of drug candidates at the earliest stages of discovery. It is the is the characterization of the physicochemical and...

Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab

Posted on13 Jan 2021

TagsGlobalpharma sanofi, Kymab, monoclonal antibody, Sanofi

Comments0

Global pharmaceutical company, Sanofi will acquire a clinical-stage biopahrmaceutical company Kymab. Sanofi will acquire Kymab for an upfront payment of approximately $1.1 billion and up to $350 million upon achievement...

Covishield received emergency use authorization in India

Posted on01 Jan 2021

TagsAstraZeneca, Covid vaccine, COVID-19, Covishield, serum institute

Comments0

Covidshield vaccine, developed by AstraZeneca and Oxford University has received for emergency use authorization in India. Drugs Controller General of India (DCGI) has recommended granting emergency use authorisation to AstraZeneca’s...

Glenmark introducing Remogliflozin + Vildagliptin combination first time in India

Posted on30 Dec 2020

TagsGlenmark, PMT in pharma, Remogliflozin etabonate, vildagliptin

Comments0

Glenmark Pharmaceuticals Limited is introducing a fixed dose combination (FDC) of Remogliflozin + Vildagliptin. Remogliflozin is Sodium Glucose Co-Transporter Inhibitor (SGLT2i). Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of...

Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx

Posted on30 Dec 2020

TagsMyovant, Orgovyx, pfizer, relugolix

Comments0

Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the brand of relugolix. Relugolix is a once-daily, oral gonadotropin-release hormone...

UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time

Posted on03 Dec 2020

TagsBioNTech, Covid vaccine, pfizer

Comments0

The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner BioNTech SE. The vaccine will be available in Britain from...

Telix Pharma to acquire TheraPharm GmbH

Posted on01 Dec 2020

TagsScintec, TheraPharm GmbH

Comments0

Telix Pharmaceuticals announced that it has entered into an agreement with Scintec Diagnostics GmbH (Scintec) to acquire TheraPharm GmbH, a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in...

Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis

Posted on28 Nov 2020

Comments0

Astellas Pharma Inc. and FibroGen, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Evrenzo (roxadustat) for the treatment of anemia of chronic kidney disease (CKD) in...

Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development

Posted on28 Nov 2020

Comments0

More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development status of the vaccine candidate. Click here to view Till...

PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease

Posted on28 Nov 2020

Tagscodevelopment deal in pharma, Drug development, drug development project

Comments0

Biotechnology company PostEra announced a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer’s disease and other dementias. The failure of late-stage clinical trials to uncover...

AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum

Posted on28 Nov 2020

Tags2015 sales of Humira, humira, pyoderma gangrenosum

Comments0

AbbVie GK and Eisai Co, Ltd announced an approval of additional indication of Humira, a fully human anti-TNFa monoclonal antibody, for the treatment of pyoderma gangrenosum (PG). Humira was granted...

Pfizer submitted application for emergency use of Covid vaccine

Posted on20 Nov 2020

TagsCovid vaccine, COVID-19, vaccine

Comments0

US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government for its dosage. Pfizer has said the emergency...

Take Self Competency Test in Esxport Documentation

Posted on20 Nov 2020

Tagsmcqs in pharma export documentation

Comments0

You can take a short and quick competency test on pharmaceutical export.

Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China

Posted on20 Nov 2020

TagsChronic Kidney Disease, CKD, Fresenius Kabi, Hyperkalemia, Veltassa, VFMCRP, Vifor Pharma

Comments0

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for the treatment of hyperkalemia in the People’s Republic of China....

US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease

Posted on20 Nov 2020

Tagsavalglucosidase alfa, Biological License Application, biological products, priority review, Priority Review Designation, USFDA Priority Review

Comments0

The US Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa for long-term enzyme replacement therapy for the treatment of patients...

Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma

Insight on why Jazz Pharmaceuticals to acquire GW Pharma?

ViiV Healthcare’s Rukobia received EMA marketing authorisation

Sanofi received additional indication approval for Plavix

CoronaVac received conditional marketing authorization from NMPA China

What is the meaning of pharmaceutical profiling?

Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab

Covishield received emergency use authorization in India

Glenmark introducing Remogliflozin + Vildagliptin combination first time in India

Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx

UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time

Telix Pharma to acquire TheraPharm GmbH

Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis

Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development

PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease

AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum

Pfizer submitted application for emergency use of Covid vaccine

Take Self Competency Test in Esxport Documentation

Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China

US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease

Biopharma Selling Skill Training

Executive Program in Biopharma Business Development and Strategic Management

KPE-C-062 KPE’s Certificate Course in Selling Skills for Medical Representatives

KPE-C-080 Certificate Course in Pharma Business Development & Licensing

KPE-C-079 KPE’s 1 Week Fundamental Training on Drug Discovery to Commercialization Pathway

KPE-C-077 – Fundamental Training on Data Integrity in pharmaceutical and biopharmaceutical industry

KPE-C-064N KPE’s 1 Month Certificate Course in Pharma Sales Management

KPE-C-103 Executive Program in Global Drug Regulatory Affairs [EPGDRA]

KPE-C-075 Fundamental Training on Pharma Marketing Plan Development

KPE-C-074 Fundamental Training on Monoclonal Antibody

KPE-C-073 Fundamental Training on Regulatory Affairs Advance Strategic Planning

KPE-C-072 Fundamental Training on 505B(2) Application Submission

Your form has been submitted

Recent updates

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?